Science & Technology
Restoring Tolerance in Inflammatory Bowel Disease with an Oral AMPK agonist Nanomedicine that Targets Antigen Presenting Cells.
Department of Health and Human Services — National Institutes of Health
Opportunity #: 1R41DK142311-01
Award Ceiling
$609K
Award Floor
$609K
Close Date
Jul 31, 2026
138 days leftTotal Funding
$609K
Expected Awards
1
Posted Date
Sep 20, 2024
Cost Sharing Required
No
Grants.gov ID
sbir-1R41DK142311-01
Description
STTR Phase Phase I award: "Restoring Tolerance in Inflammatory Bowel Disease with an Oral AMPK agonist Nanomedicine that Targets Antigen Presenting Cells." awarded to Qrono, Inc. in Pittsburgh, Pennsylvania. Funded by Department of Health and Human Services (National Institutes of Health). Award amount: $608,877. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses, HUBZone businesses
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.